Venture capital Archives

europe biotech ey finance growth pharma industry 2016

News and Trends 12 Apr 2016

How was the Biotech Financial World in 2015? Unprecedented!

Biotech is still breaking funding records. A new report by EY provides an interesting analysis of how Biotech is doing, globally and in Europe. Although 2015 was the best for Biotech yet, but there is a slowdown coming – that’s the gist of EY’s recent report: ‘Beyond borders 2016: Biotech financing‘. This well-known auditing and […]

April 12, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 11 Sep 2015

Biom’Up funding goes up Up UP! Surgery tech gets new pot of €31.3M VC

Biom’Up is a Lyon (Fr) Med-tech company which produces biopolymer devices to improve surgery. Launch of their new product Hemoblast has triggered a series C investment round from a large syndicate of European venture capitals. Biom’Up was founded in 2005, experiencing exponential growth since with their biopolymer tech development which achieved a €3M turnover in […]

September 11, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 23 Jul 2015

Biotech investors are back in Germany

Things are looking good for German Biotechs! At least, this is what the general mood at the international congress organized by the IZB on July 16th and 17th 2015 in Martinsried, near Munich, reflected. A bunch of international investors and decision makers gathered to show that the sector is picking up momentum again in Germany! The Innovation and Startup […]

July 23, 2015 - 4 minutesmins - By Joachim Eeckhout

News and Trends 28 Jun 2015

Google and big names helped Oxford Sciences Innovation to raise €457M

Oxford Sciences Innovation has completed the second close of its fundraising, raising an additional €157.3M (£110M) and bringing the total amount raised to €457.6M (£320M). This second close included some well-known investors such as Google Ventures and Charles Dunstone. Being backed by one of the best-recognized institutions in the world has its advantages. Oxford University […]

June 28, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 23 Jun 2015

Chris Viehbacher to run Swiss billionaire’s investment fund

One of our favorite bio-celebrities is enlarging his CV with a new job position. The German-Canadian Chris Viehbacher will run the billionaire Gurnet Point Capital fund, owned by the Swiss magnate Ernesto Bertarelli. If Chris Viehbacher felt disappointed after being dumped from Sanofi, at least he didn’t lose his pharma thrill. Recently, however, the business […]

June 23, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 9 Jun 2015

Kurma Partners announces the launch of its third fund Kurma Diagnostics

Kurma Diagnostics (KDx), the first Venture Capital fund dedicated to financing early-stage European innovative Diagnostic projects and companies, is here to stay. The firm Kurma Partners, author of this initiative, has received the support from several European and French institutions. The fund has raised €33 Million in its first fundraising round. KDx is a venture […]

June 9, 2015 - 2 minutesmins - By Nicolas Sainte-Foie

News and Trends 23 Mar 2015

Life Sciences have a new big player: Joint Polish Investment Fund Management

Poland’s first Institutional Venture Capital Fund dedicated to Life Sciences announced today the first closing of its new venture capital fund at €38.5M. Joint Polish Investment Fund Management (JPIF), headed by Dr. Marek Orłowski, is the first institutional venture capital fund operating out of Poland that is completely dedicated to life science investments. The fund […]

March 23, 2015 - 3 minutesmins - By Lourdes Riquelme

News and Trends 6 Jan 2015

The largest VC investment in a single Biotech company has just been made

Wow, 2015 starts in a rush for the biotech industry. Moderna Therapeutics, Boston-based company led by French co-founding CEO Stephan Bancel just raised $450M (€380M) in VC investment. According to The Wall Street Journal, it is the largest VC-Investment ever made in a Biotech company. Moderna was founded only in 2011 and is an awesome company […]

January 6, 2015 - 1 minutemin - By Philip Hemme

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us